Steven E Nissen Selected Research

Antihypertensive Agents (Antihypertensives)

1/2023	Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
4/2012	Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study.
12/2006	Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
11/2004	Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven E Nissen Research Topics

Disease

80	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 05/2003
75	Atherosclerotic Plaque (Atheroma) 01/2024 - 02/2003
42	Atherosclerosis 12/2023 - 02/2002
41	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 03/2000
41	Myocardial Infarction 01/2024 - 07/2002
30	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2005
29	Stroke (Strokes) 01/2024 - 11/2005
24	Acute Coronary Syndrome 01/2022 - 03/2000
20	Coronary Disease (Coronary Heart Disease) 01/2018 - 11/2003
17	Disease Progression 02/2021 - 01/2005
16	Obesity 04/2024 - 06/2006
16	Heart Failure 01/2024 - 05/2003
16	Inflammation (Inflammations) 12/2023 - 02/2003
15	Unstable Angina 10/2022 - 07/2002
11	Weight Loss (Weight Reduction) 04/2024 - 04/2008
11	Atrial Fibrillation 01/2024 - 08/2015
11	Hypertension (High Blood Pressure) 01/2023 - 06/2006
11	Vascular Diseases (Vascular Disease) 10/2022 - 09/2007
9	Body Weight (Weight, Body) 01/2024 - 04/2008
9	Diabetes Mellitus 01/2021 - 06/2010
8	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2024 - 01/2022
8	Pathologic Constriction (Stenosis) 08/2018 - 03/2003
7	Rheumatoid Arthritis 09/2022 - 04/2009
6	Aortic Valve Stenosis (Aortic Stenosis) 04/2024 - 05/2003
6	Neoplasms (Cancer) 10/2022 - 01/2009
6	Osteoarthritis 09/2022 - 04/2009
6	AIDS-Related Complex (ARC) 02/2022 - 08/2014
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 07/2006
5	Thrombosis (Thrombus) 12/2023 - 08/2006
5	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2023 - 01/2021
5	Arthritis (Polyarthritis) 09/2022 - 04/2009
5	COVID-19 03/2022 - 08/2020
5	Dyslipidemias (Dyslipidemia) 12/2020 - 03/2007
4	Chest Pain (Chest Pains) 01/2019 - 03/2000
3	Cholelithiasis 01/2024 - 04/2023
3	Gout 01/2024 - 04/2023
3	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2019
3	ST Elevation Myocardial Infarction 01/2022 - 02/2003
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 04/2008
3	Ischemia 01/2019 - 03/2000

Drug/Important Bio-Agent (IBA)

62	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 02/2003
36	LipidsIBA 05/2024 - 11/2003
31	oxidized low density lipoproteinIBA 05/2024 - 04/2006
30	LDL CholesterolIBA 01/2024 - 01/2005
25	HDL CholesterolIBA 03/2022 - 11/2003
24	C-Reactive ProteinIBA 01/2024 - 10/2003
24	Atorvastatin (Lipitor)FDA Link 01/2019 - 03/2004
21	omega-Chloroacetophenone (Mace)IBA 01/2024 - 05/2010
19	Rosuvastatin Calcium (Crestor)FDA Link 08/2017 - 04/2006
12	Lipoproteins (Lipoprotein)IBA 05/2024 - 01/2005
12	Lipoprotein(a)IBA 04/2024 - 08/2017
12	evacetrapibIBA 10/2022 - 11/2011
11	CholesterolIBA 01/2024 - 02/2007
10	Cholesterol Ester Transfer ProteinsIBA 10/2022 - 12/2008
10	Triglycerides (Triacylglycerol)IBA 03/2022 - 03/2007
9	evolocumabIBA 01/2023 - 06/2016
8	Testosterone (Sustanon)FDA Link 02/2024 - 01/2022
8	Naproxen (Naprosyn)FDA LinkGeneric 09/2022 - 04/2009
8	Celecoxib (Celebrex)FDA Link 09/2022 - 04/2009
8	Ibuprofen (Motrin)FDA LinkGeneric 09/2022 - 04/2009
8	CalciumIBA 01/2021 - 01/2007
8	HDL LipoproteinsIBA 12/2020 - 03/2006
8	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2016 - 11/2003
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2005
7	Insulin (Novolin)FDA Link 02/2022 - 04/2008
7	Phenobarbital (Luminal)FDA Link 08/2018 - 03/2003
6	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2024 - 04/2023
6	alogliptinIBA 01/2020 - 10/2011
6	Pioglitazone (Actos)FDA Link 01/2019 - 11/2005
5	EnzymesIBA 11/2023 - 10/2003
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2020 - 01/2005
5	ApolipoproteinsIBA 01/2018 - 02/2007
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 04/2008
5	Amlodipine (Norvasc)FDA LinkGeneric 04/2012 - 11/2004
5	Enalapril FDA LinkGeneric 04/2012 - 11/2004
5	Pravastatin (Pravachol)FDA LinkGeneric 07/2008 - 03/2004
4	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2024 - 01/2016
4	Hemoglobins (Hemoglobin)IBA 02/2024 - 04/2008
4	Liraglutide FDA Link 01/2024 - 11/2013
4	CreatinineIBA 11/2023 - 03/2007
4	MYK-461IBA 10/2023 - 01/2021
4	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 11/2004
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2022 - 04/2009
4	TroponinIBA 08/2021 - 03/2000
4	Apolipoproteins B (ApoB)IBA 12/2020 - 07/2008
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 05/2014
3	Myosins (Myosin)IBA 01/2023 - 12/2022
3	Dihydrotachysterol (AT 10)IBA 03/2022 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 01/2011
3	Proprotein Convertase 9IBA 02/2021 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2007

Therapy/Procedure

98	Therapeutics 05/2024 - 05/2003
18	Bariatric Surgery 04/2024 - 04/2012
8	Glycemic Control 04/2024 - 09/2007
8	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2022 - 04/2012
8	Gastrectomy 03/2022 - 04/2012
5	Percutaneous Coronary Intervention 08/2020 - 02/2003
4	Drug Therapy (Chemotherapy) 01/2024 - 12/2020
3	Operative Surgical Procedures 12/2023 - 11/2021
3	Secondary Prevention 01/2022 - 11/2003